Century Therapeutics Adds Veteran Deal-Makers to Board as Pipeline Nears Clinic
PHILADELPHIA, PA — Century Therapeutics, Inc. (NASDAQ: IPSC) has appointed Han Lee, Ph.D., M.B.A., and Martin Murphy, Ph.D., to its board of directors, strengthening governance and strategic oversight as the …
Century Therapeutics Adds Veteran Deal-Makers to Board as Pipeline Nears Clinic Read More